Noninvasive diagnostic of periprosthetic joint infection by urinary peptide markers: A preliminary study
Mohamed Omar Henning Windhagen Christian Krettek Max Ettinger
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 339-347
Open
Noninvasive diagnostic of periprosthetic joint infection by urinary peptide markers: A preliminary study
Mohamed Omar Henning Windhagen Christian Krettek Max Ettinger
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 339-347
Open
An automated real‐time PCR assay for synovial fluid improves the preoperative etiological diagnosis of periprosthetic joint infection and septic arthritis
Fan Yang Hyonmin Choe Naomi Kobayashi Taro Tezuka Masatoshi Oba Yushi Miyamae Akira Morita Koki Abe Yutaka Inaba
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 348-355
Open
N‐acetylcysteine use as an adjuvant to bone cement to fight periprosthetic joint infections: A preliminary in vitro efficacy and biocompatibility study
Kamolsak Sukhonthamarn Jeongeun Cho Emanuele Chisari Karan Goswami William V. Arnold Javad Parvizi
2021
Journal of Orthopaedic Research Volume 39, Issue 2 p. 356-364
Open
Novel microcomposite implant for the controlled delivery of antibiotics in the treatment of osteomyelitis following total joint replacement
Serkan Inceoglu Gary Botimer Victoria K. Maskiewicz
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 365-375
Open
Impact of low bone mass and antiresorptive therapy on antibiotic efficacy in a rat model of orthopedic device‐related infection
Keith Thompson Linda Freitag Ursula Styger Karin Camenisch Stephan Zeiter Daniel Arens R. Geoff Richards Thomas F. Moriarty Vincent A. Stadelmann
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 415-425
Open
Single‐stage revision of MRSA orthopedic device‐related infection in sheep with an antibiotic‐loaded hydrogel
Andrew L. Foster Willemijn Boot Valentina Stenger Matteo D'Este Anjali Jaiprakash David Eglin Stephan Zeiter Robert G. Richards Thomas F. Moriarty
2021
Journal of Orthopaedic ResearchVolume 39, Issue 2 p. 438-448
Open
Antibiotics and cement: what I need to know?
Pellegrini AV, Suardi V.
2020
Antibiotics and cement: what I need to know? HIP International. 2020;30(1_suppl):48-53.
Open
How reliable is the next generation of multiplex-PCR for diagnosing prosthetic joint infection compared to the MSIS criteria? Still missing the ideal test
Lausmann C, Kolle KN, Citak M, et al.
2020
How reliable is the next generation of multiplex-PCR for diagnosing prosthetic joint infection compared to the MSIS criteria? Still missing the ideal test. HIP International. 2020;30(1_suppl):72-77.
Open
ANTIBIOTIC PROPHYLAXIS FOR URINARY CATHETER MANIPULATION FOLLOWING ARTHROPLASTY: A SYSTEMATIC REVIEW
T. Roberts T. Smith H. Simon C. Goodmaker C. Hing
2020
VOLUME 27, SUPPLEMENT 1, S10, OCTOBER 01, 2020
Open
Experimental reproduction of periprosthetic joint infection: Developing a representative animal model
López-Torres, Irene Isabel; Sanz-Ruíz, Pablo; Navarro-García, Federico; León-Román, Victor Estuardo; Vaquero-Martín, Javier
2020
The Knee, ISSN: 0968-0160, Vol: 27, Issue: 3, Page: 1106-1112
Open
How I do it…. How infection doctors approach the PJI MDT
Jenkins, Neil; Hughes, Harriet
2020
The Knee, ISSN: 0968-0160, Vol: 27, Issue: 6, Page: 1994-1997
Open
S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
Najm, W.I., Reinsch, S., Hoehler, F. et al.
2004
S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]. BMC Musculoskelet Disord 5, 6 (2004).
Open
The North Staffordshire Osteoarthritis Project – NorStOP: Prospective, 3-year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults
Thomas, E., Wilkie, R., Peat, G. et al.
2004
The North Staffordshire Osteoarthritis Project – NorStOP: Prospective, 3-year study of the epidemiology and management of clinical osteoarthritis in a general population of older adults. BMC Musculoskelet Disord 5, 2 (2004).
Open
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial
Curtis, S.P., Bockow, B., Fisher, C. et al.
2005
Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. BMC Musculoskelet Disord 6, 58 (2005).
Open
Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses
Rosemann, T., Wensing, M., Joest, K. et al.
2006
Problems and needs for improving primary care of osteoarthritis patients: the views of patients, general practitioners and practice nurses. BMC Musculoskelet Disord 7, 48 (2006).
Open
Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany
Rosemann, T., Laux, G. & Kuehlein, T.
2007
Osteoarthritis and functional disability: results of a cross sectional study among primary care patients in Germany. BMC Musculoskelet Disord 8, 79 (2007).
Open
Constructing osteoarthritis through discourse – a qualitative analysis of six patient information leaflets on osteoarthritis
Grime, J.C., Ong, B.N.
2007
Constructing osteoarthritis through discourse – a qualitative analysis of six patient information leaflets on osteoarthritis. BMC Musculoskelet Disord 8, 34 (2007).
Open
A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models
Sniekers, Y.H., Intema, F., Lafeber, F.P. et al.
2008
A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord 9, 20 (2008).
Open
Fatigue in osteoarthritis: a qualitative study
Power, J.D., Badley, E.M., French, M.R. et al.
2008
Fatigue in osteoarthritis: a qualitative study. BMC Musculoskelet Disord 9, 63 (2008).
Open
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
Fleischmann, R., Tannenbaum, H., Patel, N.P. et al.
2008
Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis. BMC Musculoskelet Disord 9, 32 (2008).
Open
Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants
Uitterlinden, E., Koevoet, J., Verkoelen, C. et al.
2008
Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants. BMC Musculoskelet Disord 9, 120 (2008).
Open
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients
Stricker, K., Yu, S. & Krammer, G.
2008
A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients. BMC Musculoskelet Disord 9, 118 (2008).
Open
Alterations in the vimentin cytoskeleton in response to single impact load in an in vitro model of cartilage damage in the rat
Henson, F.M., Vincent, T.A.
2008
Alterations in the vimentin cytoskeleton in response to single impact load in an in vitro model of cartilage damage in the rat. BMC Musculoskelet Disord 9, 94 (2008).
Open
Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation
Karsdal, M., Byrjalsen, I., Leeming, D. et al.
2008
Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation. BMC Musculoskelet Disord 9, 153 (2008).
Open